GEN Edge - Latest

Latest

All

Drug Discovery

Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration

Genome Editing

Patient Dies in Beam Trial of SCD Candidate; Company Cites Conditioning

Drug Discovery

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients

Drug Discovery

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts

OMICs

10x, Bruker Launch New Single Cell Products

Infectious Diseases

Recursion Advances AI-Based C. Diff Candidate to Phase II

Drug Discovery

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration

Genome Editing

StockWatch: Sangamo Shares Surge on Shorter Pathway for Fabry Candidate

Cancer

New CEO Leads CRI’s Fight vs. Cancer: “People x Biology x Data”

Drug Discovery

Seaport Eyes Platform, Pipeline Growth with $225M Series B

Genome Editing

StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR

Drug Discovery

Immusoft Reports Promising Early Data for Lead Candidate in MPS I

Drug Discovery

Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration

GEN Edge

StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer

Artificial Intelligence

Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology

Drug Discovery

Diverse Genomes Make Medicine More Equitable

OMICs

Vizgen, Ultivue Merge, Further Consolidating Spatial Biology

Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

Drug Discovery

Kick Start: Judo Bio Takes a Page from Alnylam with $100M Launch

Cancer

Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma

Genome Editing

Prime Medicine Inks Up-to-$3.5B Collaboration with BMS, Narrows Pipeline

OMICs

StockWatch: Turnaround Lifts GeneDx Stock 3,600%, with Profitability Near

Drug Discovery

Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials

Artificial Intelligence

Nvidia Launches AI Reference Workflow for Drug Discoverers

Artificial Intelligence

Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration

Drug Discovery

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat

Industry News

Double Impact: Interest Rates and Prospects For Biotech Growth

Drug Discovery

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors

Drug Discovery

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial

Drug Discovery

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages